Brain Behavior and ImmunityNeurosciencePeer-reviewed journal article
Chronic hM3Dq signaling in microglia ameliorates neuroinflammation in male mice
William Binning, Aja E. Hogan-CanniD, Diana Yae Sakae, Matthew MaksoudiD, Valeriy G. OstapchenkoiD, Mohammed Al‐OnaiziiD, Sara MatoviciD, Wei-Yang Lu, Marco A. M. PradoiD, Wataru InoueiD, Vânia F. PradoiD
Abstract
Microglia express muscarinic G protein-coupled receptors (GPCRs) that sense cholinergic activity and are activated by acetylcholine to potentially regulate microglial functions. Knowledge about how distinct types of muscarinic GPCR signaling regulate microglia function in vitro and in vivo is still poor, partly due to the fact that some of these receptors are also present in astrocytes and neurons. We generated mice expressing the hM3Dq Designer Receptor Exclusively Activated by Designer Drugs (DREADD) selectively in microglia to investigate the role of muscarinic M3Gq-linked signaling. We show that activation of hM3Dq using clozapine N-oxide (CNO) elevated intracellular calcium levels and increased phagocytosis of FluoSpheres in vitro. Acute treatment with CNO in vivo did not affect male mouse behavior, however chronic CNO treatment decreased sickness behavior triggered by lipopolysaccharide (LPS) treatment. Interestingly, whereas acute treatment with CNO increased synthesis of cytokine mRNA, chronic treatment attenuated LPS-induced cytokine mRNA changes in the brain, likely explaining the improvement in sickness behavior by chronic hM3Dq activation. No effect of CNO was observed in DREADD-negative mice. These results suggest that chronic activation of M3 muscarinic receptors (the hM3Dq progenitor) in microglia, and potentially other Gq-coupled GPCRs, preconditions microglia to decrease their response to further immunological challenges. Our results indicate that hM3Dq can be a useful tool to modulate neuroinflammation and study microglial immunological memory in vivo, which may be applicable for manipulations of neuroinflammation in neurodegenerative and psychiatric diseases. HighlightsO_LIMicroglial function was manipulated by specific activation of hM3Dq signaling. C_LIO_LIChronic hM3Dq activation prevented LPS-induced sickness behavior in mice. C_LIO_LIMicroglial hM3Dq signaling modulated expression of pro-inflammatory cytokines. C_LI
- Citations
- 49
- FWCI
- 2.90
- Field percentile
- top 8%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Microglial activation results in neuron-type-specific increase in mPFC GABAergic transmission and abnormal behavior in mice
Binliang Tang, Jinxiang Jiang, … Li Yang·bioRxiv·Jun 13, 2020
- Microglial engulfing of glutamatergic inputs and diminished excitability of D1 medium spiny neurons of the nucleus accumbens by peripheral inflammatory insult
Shingo Nakajima, Anita Kabahizi, … Stephanie E. Fulton·bioRxiv·Dec 2, 2024
- Partial overlap in the symptom profile induced by microglia activation and systemic inflammation
Priscila Batista da Rosa, Sílvia Castany, … David Engblom·bioRxiv·Mar 4, 2026
- Chemogenetic manipulation of microglia inhibits neuroinflammation and neuropathic pain in mice
Min‐Hee Yi, Yong Liu, … Long‐Jun Wu·Brain Behavior and ImmunityPeer-reviewed·Nov 20, 2020
- Histone deacetylase 3 regulates microglial function through histone deacetylation
Laura Meleady, Morgan Towriss, … Annie Vogel Ciernia·EpigeneticsPeer-reviewed·Jul 28, 2023
- Naive Huntington's disease microglia mount a normal response to inflammatory stimuli but display impaired development of innate immune tolerance that can be counteracted by ganglioside GM1
Noam Steinberg, Danny Galleguillos, … Simonetta Sipione·bioRxiv·Apr 5, 2023